RWM
GILD icon

Rialto Wealth Management’s Gilead Sciences GILD Stock Holding History

Rialto Wealth Management’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$138K Buy
1,091
+20
+2% +$2.63K 0.03% 202
2026
Q1 		$149K Buy
1,071
+26
+2% +$3.64K 0.03% 175
2025
Q4 		$128K Buy
1,045
+6
+0.6% +$729 0.03% 188
2025
Q3 		$115K Buy
1,039
+7
+0.7% +$796 0.03% 189
2025
Q2 		$114K Buy
1,032
+15
+1% +$1.6K 0.03% 188
2025
Q1 		$114K Buy
1,017
+17
+2% +$1.75K 0.04% 181
2024
Q4 		$92.4K Buy
+1,000
New +$90K 0.03% 202

Other funds holding GILD

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Rialto Wealth Management's GILD Position: Q2 2026 in Review

Rialto Wealth Management increased its Gilead Sciences (GILD) stake by 1.9% in Q2 2026, buying an estimated $2.63K and bringing the position to 1,091 shares worth $138K. The position accounts for 0.03% of the portfolio, ranked #202.

Rialto Wealth Management first reported a position in GILD in Q4 2024 and has held it in 7 quarters since. The position peaked at $149K in Q1 2026. 2,278 funds tracked by Wall St. Rank hold GILD as of Q2 2026.

  • Rialto Wealth Management held 1,091 shares of Gilead Sciences worth $138K as of Q2 2026.
  • Rialto Wealth Management bought 20 Gilead Sciences shares in Q2 2026, an estimated $2.63K.
  • Gilead Sciences made up 0.03% of Rialto Wealth Management's portfolio in Q2 2026, its #202 holding.
  • Rialto Wealth Management first reported a position in Gilead Sciences in Q4 2024 and has held it in 7 quarters since.
  • Rialto Wealth Management's Gilead Sciences position peaked at $149K in Q1 2026.
  • 2,278 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2026.

Based on Rialto Wealth Management's 13F filing for Q2 2026, filed 11 Aug 2026.